An exciting discussion about AI in drug discovery from a highly cross disciplinary group of experts covering natural products chemistry, biotechnology, computer science, intellectual property, and standards. The episode was recorded live in t
This episode covers the July 27th House Oversight Committee within the Health Care and Financial Services Subcommittee titled “Hemp in the Modern World: The Yearslong Wait for FDA Action”. The group also discusses new data from analyzing Delta-
The third and final episode of our Live from Psychedelic Science series focuses on culture. Our team interviewed eight speakers and exhibitors from the conference hailing from various walks of life. The episode kicks off with a psychedelics c
The second episode of our three part series, Live from Psychedelic Science, focuses on business. We interview seven founders and initiative leaders operating across marketing, legal, standards, drug development, insurance, and ESG. Listeners
The first episode of our three part series, Live from Psychedelic Science, focuses on research. We interview five leaders in the field whose work runs the gamut from generating novel molecules to patient care. We kick off the episode with bac
This episode features two special guests, David Bronner and Angela Carter, ND, discussing hot topics in drug policy with co-hosts Jahan Marcu, PhD, and Nigam B. Arora, PhD. David Bronner is the CEO of Dr. Bronner’s, the highest scoring B Corp
We bring you six interviews with leaders in the psychedelics industry who will be presenting at the Psychedelic Therapeutics and Drug Development Conference taking place in San Francisco on May 15 and 16, 2023. The episode spans a variety of t
We welcome a true pioneer of psychedelics science, Dr. David Nichols, to the show. The episode begins with panelists matching quotes about psychedelics to the famous person who gave the quote, and the substance they were referring to. The pop
We get together for this episode to discuss everything from the legacy of the late Raphael Mechoulam, PhD, to the economics of THC and regulated cannabis. This episode features Joshua Hartsel, PhD and the show begins with a fun look at Dr. Mech
We host Super Bowl XLVII (2013) winner Kelechi Osemele for a sports focused episode! HLI cast member Anna Symonds weighs in heavily having won both the USA Rugby Division I National Championship and Sydney Premiership Championship. The episod
Join us as we blend perspectives on modern medical research with valuable lessons learned through other ways of knowing. Dr. Bia Labate, executive director of Chacruna Institute, and Dr. Harry McIlroy, clinical director at BioReset Medical, he
We wrap up 2022 with a psychedelics focused episode. Listeners are invited to join the conversation with experts working in legal, standards, research funding, and science aspects of the burgeoning industry. The episode kicks off with a game a
Experts discuss the science of taking the trip out of psychedelics while maintaining the therapeutic benefits, a conversation inspired by a recent article published in Nature. Psychedelics policy is also addressed with a game that tests our gue
Join us for a fun, engaging session where we discuss important issues in cannabis testing, alcohol use, and the psychedelic receptorome. This episode was our first recorded in person, and from the beautiful surroundings of the Mendocino County
This episode starts with a game that tests your knowledge about cannabis sustainability, the environmental impact of hemp operations, and proposed solutions. For our second segment, we discuss reciprocity and sustainability in psychedelics, ins
The group discusses cannabis education, happenings at the FDA, and serotonin syndrome related to psychedelics. There are increasing numbers of universities and colleges offering professional programs and even degrees in cannabis-related areas.
Join us for a conversation about novel drug substances! The topics range from clinical research to the forces within the cannabis industry’s patent and intellectual property issues. In this episode’s game, Dr. Marcu reads clues about cannabis
Join us for a psychedelics-focused conversation! Listeners of this podcast episode will enjoy discussions about the basics of serotonin and dopamine, mechanisms of action for psychedelics and antidepressants, different types of patents and thei
Join us for a cannabis-focused episode. Our discussion covers some of the politics around federal legalization in the United States, DEA licensed cultivation operators, and research into the potential for cannabis markets in Ukraine and other p
This episode features Jackie von Salm, PhD, Anna Symmonds, MA, Jahan Marcu, PhD and Nigam B. Arora, PhD. The podcast starts with a game about cannabis mergers, testing our guest’s knowledge of the recent merger between Cresco Labs and Columbia
Amber Wise, PhD, hosts this episode. Dr. Wise moderates a discussion between Miyabe Shields, PhD, Julie Kowalski, PhD, Nigam B. Arora, PhD, and Jahan Marcu, PhD. The group shares insights into psychedelics based health care as well as discussin
Jahan Marcu, PhD and Nigam B. Arora, PhD are joined by Sara Jane Ward, PhD and Jim Mitchell, PhD the Vice President, API Research and Development at Benuvia Manufacturing. The discussions begin with a deep dive into cannabis and psychedelics po
Jahan Marcu, PhD moderates the discussion with Nigam B Arora, PhD, David Vaillencourt, MSc from the GMP collective with special guest Gene Ray MSc, Lab Manager at Garden Remedies. We discuss new research on stupidity, psychedelic healthcare inv
Jahan Marcu, PhD and Nigam B. Arora, PhD host a conversation with Vertosa’s CSO Harold Han, PhD and their Chief Innovation Officer, Austin Stevenson, MSc. In this episode we focus on how cannabis and psychedelics companies keep their businesses
Today’s discussion features Jahan Marcu, PhD, Nigam B. Arora, PhD, David Vaillencourt, MSc., with special guests Kim Napoli, JD, and Marc Ross, JD from the law offices of Vicente Sederberg. We start off by discussing news around the FDA and CBD